Retatrutide
GIP/GLP-1/Glucagon Receptor Agonist
Size: 20mg
Volume Discounts Available
Tap a tier to auto-fill the quantity
3rd Party Tested
99.5% Purity
COA Included
Same Day Ship
Ships: Worldwide, tracked — Australia, USA, Canada & Europe in 1–2 business days · rest of the world 7 business days
For Research Use Only — Not for Human Consumption
This product is intended solely for in-vitro laboratory research. Not approved by the FDA, TGA, or any regulatory body for human or animal use.Full Disclaimer
Why pay more than a cheap import? Because you actually know what you're getting.
Overview
Retatrutide is a novel triple agonist peptide targeting GIP, GLP-1, and glucagon receptors simultaneously. This multi-receptor approach represents an advanced research tool for investigating complex metabolic regulation, energy expenditure, and integrated hormone signalling systems. The compound is utilised in research to study the synergistic effects of multi-incretin receptor activation and its implications for understanding metabolic homeostasis at a systemic level.
Research Uses
Retatrutide is supplied exclusively for laboratory research use and has been employed in controlled experimental studies examining:
Triple receptor agonism mechanism studies
Metabolic rate and energy expenditure research
Glucose and lipid metabolism pathway investigation
Body composition changes in experimental models
Hepatic glucose production modulation studies
Comparative multi-agonist pharmacology
All applications are limited to non-clinical research systems designed to elucidate fundamental biological mechanisms.
RESEARCH USE ONLY
This product is intended for laboratory research use only. Not for human or veterinary use. All studies utilising this compound must be conducted in controlled research environments by qualified personnel.
Verified Researcher Reviews
No reviews yet for this product. Be the first to review it.